🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to determine if intervening with combined local the...
Status
Completed
Location
Fudan Universtiy Shanghai Cancer Center
Start Date
2019-02-01
Trial ID
NCT03904927
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
A two-part trial in patients with metastic Ewing's sarcoma. Participants in...
Status
Completed
Location
Arkansas Children's Hospital
Start Date
2016-02-10
Trial ID
NCT02511132
Treatments Being Tested
This pilot feasibility study aims to set the foundation to investigate the ...
Status
Recruiting
Location
National University Hospital
Start Date
2023-02-13
Trial ID
NCT05381038
Treatments Being Tested
This is a phase 1b prospective, single arm, open-label trial determining th...
Status
Recruiting
Location
Chao Family Comprehensive Cancer Center, University
Start Date
2025-06-27
Trial ID
NCT05733689
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study ...
Status
Terminated
Location
Mayo Clinic
Start Date
2020-09-23
Trial ID
NCT04553692
This study is designed for participants who have cancer of the upper gastro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-05-19
Trial ID
NCT04931420
This is a multicenter Phase 1b, open-label study to assess safety, tolerabi...
Status
Active Not Recruiting
Location
Exelixis Clinical Site #53
Start Date
2017-09-05
Trial ID
NCT03170960
Treatments Being Tested
To evaluate the safety and tolerability of sotorasib administered in invest...
Status
Active Not Recruiting
Location
Arizona Oncology Associates Professional Corporation
Start Date
2019-12-17
Trial ID
NCT04185883
Anlotinib hydrochloride is a multi-target antiangiogenic drug. It was recom...
Status
Unknown
Location
Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine
Start Date
2019-12-30
Trial ID
NCT04757779
Treatments Being Tested